Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...
November is National Diabetes month, and it’s a great time to raise awareness about diabetes and to learn how to prevent or delay Type 2 diabetes, especially if it runs in your family. Well, let me ...
Researchers believe discovery will springboard research to make more tolerable, effective weight loss treatments accessible ...
Since the start of 2024, Wockhardt’s stock price has almost tripled to Rs 1,233.85 per share as on November 8.
Currently, Gan & Lee has six core insulin products, including five insulin analog varieties: long-acting glargine injection (Basalin®), fast-acting lispro injection (Prandilinâ„¢), fast-acting aspart ...
1,2 The findings of these studies suggest that administration of the long-acting analog insulin glargine increases the risk of cancer in patients with diabetes mellitus, whereas the biguanide ...
Semaglutide offers a multifaceted approach to type 2 diabetes treatment, enhancing insulin release and reducing blood sugar ...
Researchers at the University of Copenhagen have developed a new weight-loss drug that may surpass the effectiveness of ...
Good afternoon, and welcome to the MannKind Corporation third quarter 2024 financial results earnings call. As a reminder, ...
Managing stress and maintaining overall health can be quite challenging in today’s fast-paced world. Many people turn to ...
In the long term ... insulin and half as regular insulin. Other practitioners cite studies suggesting that a more intensive, four-times-daily regimen of short-acting and intermediate-acting ...
Scientists from the University of Copenhagen say they have developed a drug that decreases appetite while increasing calorie ...